Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Lupus ; 27(5): 788-793, 2018 Apr.
Article in English | MEDLINE | ID: mdl-29251169

ABSTRACT

Objective (a) to assess the prevalence of functional gastrointestinal disorders (FGIDs) in female Mexican systemic lupus erythematosus (SLE) patients using the Rome III criteria and (b) to examine the effect of disease duration on FGID prevalence. Methods Female SLE outpatients aged ≥18 years with no organic gastrointestinal disorder were included. Participants were invited to upper gastrointestinal endoscopy screening and a faecal immunochemical test. FGID symptoms were evaluated using the Rome III questionnaire. Results Eighty-six SLE patients with median age of 45 (interquartile range 34-54) years were included. At least one FGID was found in 76.7% (66/88) of patients with SLE. The most prevalent domains of FGID diagnosed were functional oesophageal, gastroduodenal disorders and bowel disorders, of which functional dyspepsia (72.7%), functional heartburn (68.1%) and bloating (63.8%) were the most frequent. Fifty-nine per cent of patients had overlapping FGIDs. The most prevalent overlap was the combination of functional dyspepsia and functional heartburn. Patients with longer disease duration had a higher prevalence of FGID than those with shorter disease duration. Conclusions There was a high prevalence of FGIDs in Mexican SLE women with low disease activity. Overlapping FGIDs were frequent. Longer disease duration may be associated with FGIDs in SLE patients.


Subject(s)
Gastrointestinal Diseases/epidemiology , Lupus Erythematosus, Systemic/epidemiology , Adolescent , Adult , Cross-Sectional Studies , Dyspepsia/diagnosis , Dyspepsia/epidemiology , Endoscopy, Gastrointestinal , Feces/chemistry , Female , Gastrointestinal Diseases/diagnosis , Heartburn/diagnosis , Heartburn/epidemiology , Humans , Immunohistochemistry , Lupus Erythematosus, Systemic/diagnosis , Mexico/epidemiology , Middle Aged , Prevalence , Surveys and Questionnaires , Time Factors , Young Adult
2.
Lupus ; 24(11): 1227-32, 2015 Oct.
Article in English | MEDLINE | ID: mdl-26085596

ABSTRACT

The objective of this cross-sectional study was to determine relationships between socioeconomic status and organ damage in Mexican systemic lupus erythematosus (SLE) patients. Demographic and clinical variables were assessed. Socioeconomic status was evaluated using the Graffar method and monthly household income. Lupus activity and organ damage were measured using the SLE disease activity scale, validated for the Mexican population (Mex-SLEDAI), and the Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) scale. The 143 Mexican female SLE patients included (mean age 40.1 ± 8.9 years, mean disease duration 8.9 ± 6.3 years) had a mean monthly household income of $ 407.2 ± 326.5. According to the Graffar index, 18.9%, 52.5%, and 28.7% had high/medium-high, medium, and medium-low/low socioeconomic status, respectively. Organ damage was observed in 61 patients (42.7%). Patients with organ damage had lower monthly household incomes ($241.4 ± 152.4 vs. $354.8 ± 288.3) and were more frequently unemployed (57.3% vs. 35.3%; p = 0.01) than those without. Low monthly income was not associated with lupus activity or self-reported health status. In the adjusted multivariate analysis, low monthly income ( < $300) was associated with organ damage. In conclusion, low income may be associated with organ damage in Mexican SLE patients.


Subject(s)
Lupus Erythematosus, Discoid/economics , Lupus Erythematosus, Discoid/pathology , Lupus Erythematosus, Systemic/economics , Lupus Erythematosus, Systemic/pathology , Multiple Organ Failure/economics , Multiple Organ Failure/pathology , Adult , Cross-Sectional Studies , Female , Health Status , Humans , Mexico , Middle Aged , Multivariate Analysis , Severity of Illness Index , Social Class , Women's Health
SELECTION OF CITATIONS
SEARCH DETAIL
...